Healthcare companies donated $19.76M to the GOP in 2017-18 election cycle

Healthcare companies flex their financial muscle when it comes to politics, and the 2017-18 election was no different with healthcare-related donations hitting $37.9 million, according to OpenSecrets.org, a website that tracks political spending.

Advertisement

Note: Only donations of $200 or more were included.

1. Although donations were almost equal among the parties, healthcare companies donated $19.76 million to Republican candidates and $18.04 million to Democratic candidates.

2. Healthcare companies supported incumbent candidates at a drastically higher rate than challengers, with $33.48 million going to incumbents.

3. Concerning the U.S. House, healthcare companies donated $14.54 million to Republican candidates and $8.98 million to Democrats.

4. In the Senate, Democrats were the largest benefactor, receiving $6.12 million in healthcare-related contributions with Republicans receiving $3.69 million. Healthcare companies also supported independent candidates donating $124,029.

5. These five legislators received the most from healthcare companies:

Sen. Claire McCaskill, D-Mo. — $774,637
House Speaker Paul Ryan, R-Wis. — $671,086
Sen. Orrin Hatch, R-Utah — $646,049
Rep. Greg Walden, R-Ore. — $606,050
Sen. Sherrod Brown, D-Ohio — $582,935

More articles on coding, billing and collections:
Allergan, Ironwood & more — 8 GI company key notes
6 top medication management standard challenges from The Joint Commission
New CAIP ASC infection prevention credential: 7 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Coding, Billing & Collections

Advertisement

Comments are closed.